We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. Read more about our Privacy Policy.

I got it!

Publication
3 pages, 4M
September 2024

EIC cell & gene therapy Pathfinder portfolio

The way the projects are selected to establish the portfolio. If the projects are selected based on common research interests (shared component), it is more likely that they would also share common innovation and business objectives and want to collaborate on mutual benefit basis, to collectively bring these into fruition.

Source: op.europa.eu